The control of oral secretions in bulbar ALS/MND

被引:56
作者
Newall, AR [1 ]
Orser, R [1 ]
Hunt, M [1 ]
机构
[1] REHABIL CTR,ALS CLIN,OTTAWA,ON K1H 8M2,CANADA
关键词
ALS/MND; oral secretion; physiology; drug therapy;
D O I
10.1016/0022-510X(96)00104-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
For the bulbar ALS/MND patient with dysphagia, the accumulation of oral secretions is a distressing problem. The control of these secretions, particularly the thick mucus form, is very difficult. In approaching this problem it is important to realise that the source of these secretions is not just from the oral salivary glands. The nose and lungs also contribute a constant flow of serous and particularly mucoid fluids. The neural control of these different forms of secretion is of importance in controlling them. Stimulation of cholinergic receptors produces thin serous secretions whereas beta adrenergic receptors produce thick protein- and mucus-rich secretions. Therefore 16 bulbar ALS/MND patients were treated with beta antagonists after maximising other therapy. 75% of this group had fast and significant relief from their thick secretions. It is therefore proposed to perform a large controlled trial of beta blockers in the control of thick oral secretions in ALS\MND based on these promising pilot data.
引用
收藏
页码:43 / 44
页数:2
相关论文
共 12 条
[1]  
Ballantyne J, 1979, SCOTT BROWNS DIS EAR, V4th
[2]  
CAROSCIO JT, 1986, AMYOTROPHIC LATERAL
[3]  
DEITMER T, 1989, PHYSL PATHOLOGY MUCO
[4]  
DOBROSIELSKIVER.K, 1993, BIOL SALIVARY GLANDS
[5]  
LEIGH PN, 1995, MOTOR NEURON DIS BIO
[6]  
MARIN ADG, 1988, LOGAN TURNERS DIS NO
[7]  
MARIN MG, 1986, PHARMACOL REV, V38, P273
[8]  
MARIN MG, 1994, PHARMACOL REV, V46, P35
[9]  
Murray J. F., 1988, TXB RESP MED
[10]   MECHANISMS OF BETA-ADRENERGIC-RECEPTOR REGULATION IN LUNGS AND ITS IMPLICATIONS FOR PHYSIOLOGICAL-RESPONSES [J].
NIJKAMP, FP ;
ENGELS, F ;
HENRICKS, PAJ ;
VANOOSTERHOUT, AJM .
PHYSIOLOGICAL REVIEWS, 1992, 72 (02) :323-367